Beranda › Infeksi Virus › Texas › Dallas
Uji klinis Infeksi Virus di Dallas, TX
4 studi untuk Infeksi Virus mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
- Research Site, Dallas
A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
- Cedar Health Research, Dallas
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
- Zenos Clinical Research, Dallas
- Southwest Family Medicine Associates, Dallas
- Southwest Mind and Body Care, Dallas
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
- Zenos Clinical Research, Dallas
- Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
- Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
- dan 1 lainnya
Uji klinis Infeksi Virus di kota lain
- Washington, DC12 studi
- Houston, TX6 studi
- Boston, MA6 studi
- Baltimore, MD5 studi
- Hialeah, FL5 studi
- Columbus, OH4 studi
- Atlanta, GA4 studi
- Cincinnati, OH4 studi
- San Francisco, CA3 studi
- St. Louis, MO3 studi
- Los Angeles, CA3 studi
- Tampa, FL3 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Kandung Kemih27 studi
- Kanker Paru27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.